Moderna Ceo Discusses Company Innovation Following Ipo

Moderna CEO discusses company innovation following IPO

CNBC Television

Moderna CEO Explains Why Making a Vaccine Is So Hard

David Rubenstein

Moderna Sharing Less Data Since IPO, CEO Says

Bloomberg Technology

Klaviyo co-founders on IPO, company operations

CNBC Television

Moderna CEO Stéphane Bancel: We're likely moving into an endemic setting

CNBC Television

Moderna CEO: Developing new class of medicine using mRNA, Amazon cloud

CNBC Television

Leadership Live With David Rubenstein: Moderna CEO Stephane Bancel

David Rubenstein

Moderna Co-Founder and Flagship Pioneering CEO on the Future of Biotech | WSJ News

Synchronoss Technologies CEO discusses cloud security, AI, and strategic growth focus

Proactive Investors

Moderna CEO Stéphane Bancel - Bringing Exponentials to Pharma

Moderna CEO talks competition with J&J, Novavax, AstraZeneca

Moderna CEO on raising Covid vaccine manufacturing goals

CNBC Television

COVID vaccine manufacturer Moderna’s CEO discusses the company’s Q3 earnings

Why this biotech analyst has a hold rating on Moderna

CNBC Television

Shares of Moderna rally on vaccine news, CEO discusses vaccine trial and efficacy

Moderna CEO on vaccines pipeline: Investing aggressively to bring important medicine to patients

CNBC Television

Moderna CEO on using mRNA, Amazon cloud to develop a new class of medicine

CNBC Television